AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 170 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,504,613 | +157.0% | 53,129 | +108.5% | 0.07% | +213.0% |
| Q1 2023 | $585,390 | +50.5% | 25,485 | +45.4% | 0.02% | +91.7% |
| Q2 2022 | $389,000 | +10.5% | 17,533 | +45.0% | 0.01% | -7.7% |
| Q1 2022 | $352,000 | -83.7% | 12,092 | -81.6% | 0.01% | -84.5% |
| Q4 2021 | $2,164,000 | -45.2% | 65,824 | -13.9% | 0.08% | -31.7% |
| Q1 2021 | $3,946,000 | +119.3% | 76,419 | +84.1% | 0.12% | +105.0% |
| Q4 2020 | $1,799,000 | +55.9% | 41,512 | +25.9% | 0.06% | -60.8% |
| Q3 2020 | $1,154,000 | – | 32,967 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
| Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
| Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
| BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
| Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
| Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
| Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
| BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
| Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
| HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |